BUZZ-SciSparc jumps as it buys acid reflux device patents, eyes global push

Reuters01-13
BUZZ-SciSparc jumps as it buys acid reflux device patents, eyes global push

** Shares of Israel-based drug developer SciSparc SPRC.O rise 56.2% to $2.29 premarket

** Co says it has signed a deal to buy patents and intellectual property for endoscopic medical devices, including the MUSE system, from Xylo Technologies

** MUSE is a single-use device for minimally invasive treatment of acid reflux disease - co

** Co says deal expected to close March 8; Xylo to get 19.99% of SciSparc's share capital or pre-funded warrants

** SPRC plans global expansion via distributors in North America, Europe, Latin America - SPRC

** As of last close, stock down ~82% over the past year

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment